Sept 25 (Reuters) - Quest Pharmatech Inc QPT.V :
* ONCOQUEST RECEIVES "NOTICE OF ALLOWANCE" FOR PATENT PROTECTION OF THE ADMINISTRATION SCHEDULE OF OREGOVOMAB AND CHEMOTHERAPY FOR STAGE III-IV OVARIAN CANCER PATIENTS
* QUEST PHARMATECH - CO IS CURRENTLY PLANNING TO LAUNCH A PHASE 3 TRIAL FOR OREGOVOMAB IN Q1 2020